SIG Group AG Earnings Call Transcripts
Fiscal Year 2026
-
Stable revenue at constant currency, improved profitability, and stronger cash flow marked Q1, with Asia Pacific and EMEA showing growth while Europe and Americas faced headwinds. Cost discipline, restructuring, and mitigation of input cost inflation remain priorities.
Fiscal Year 2025
-
Sequential improvement in Q4 led to modest full-year growth, with strong performance in the Americas and continued innovation. EUR 351 million in non-recurring charges impacted results, but guidance for 2026 anticipates stable to modest growth and margin improvement.
-
Leadership is driving an operational reset with a focus on aseptic technology, innovation, and disciplined capital allocation. Guidance targets 0-2% organic growth in 2026, 3-5% mid-term, margin expansion, and improved cash flow, with sustainability and portfolio optimization as key pillars.
-
Q3 saw revenue and EBITDA decline due to weak consumer sentiment, customer destocking, and €320 million in non-recurring impairment charges. Guidance for 2025 is flat to slightly negative revenue growth, with a focus on capital discipline and paused dividend. Net leverage rose to 3.3x but is expected to fall by year-end.
-
Revenue grew 2.1% in H1 2025 despite subdued markets, with strong innovation and share gains. Adjusted EBITDA margin reached 23.6%, but FX headwinds and higher customer incentives weighed on free cash flow. FY guidance narrowed to lower end of 3%-5% revenue growth and 24.5%-25.5% EBITDA margin.
-
Q1 2025 saw 3.2% revenue growth at constant currency and resin, with adjusted EBITDA margin up to 22.3%. Guidance for 3%-5% annual growth and 24.5%-25.5% EBITDA margin is maintained, with H2 expected to be stronger due to new filler installations and operational efficiencies.
Fiscal Year 2024
-
Revenue grew 4% in 2024, with strong share gains and innovation offsetting market softness. Adjusted EBITDA rose to EUR 820 million, free cash flow increased 30%, and net leverage improved to 2.6x. 2025 guidance targets 3–5% revenue growth and a 24.5–25.5% EBITDA margin.
-
Q3 saw continued revenue and EBITDA growth, with strong carton performance and improving bag-in-box operations. Regional diversification and operational improvements supported results, while guidance for full-year growth and margins was reaffirmed. Net leverage and free cash flow improved.
-
Carton segments outperformed with strong growth, while bag-in-box and spouted pouch lagged due to North American demand softness and operational issues. Guidance was revised lower for EBITDA margin, but revenue growth is expected to improve, supported by ongoing remediation and strong filler placements.